Loading stock data…
ELAN
$22.51+0.14 (+0.63%)
Market ClosedLast close May 1
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Elanco Animal Health Incorporated in the Healthcare sector is trading at $22.51. The stock is currently 19% below its 52-week high of $27.72, remaining 4.7% above its 200-day moving average. Technical signals show neutral RSI of 37 and bearish MACD signal, explaining why ELAN maintains its current momentum and trend strength. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 37) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$22.51
Potential Upside
5%
Whystock Fair Value$23.64
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Mean target$28.57+26.9%
Range$20.00 – $32.00
Fundamentals
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that p...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.06B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.88
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.63%
Volume
Today's trading volume
3.28M
Recent News
Evaluating Elanco Animal Health (ELAN) After New Emergency Screwworm Treatment Authorizations
Elanco Animal Health (ELAN) is back in focus after U.S. regulators granted Emergency Use Authorization for Negasunt Powder and a Section 18 Emergency Exemption for Tanidil to address New World screwworm risks near the U.S. border. See our latest analysis for Elanco Animal Health. The EUA news arrives after a softer patch in the share price, with a 30 day share price return of a 6.5% decline and a 90 day share price return of a 7.1% decline. However, the 1 year total shareholder return of...
Jim Cramer Says “You’ve Got a Winner in CCJ”
Cameco Corporation (NYSE:CCJ) was among the stocks on Jim Cramer’s Mad Money radar as he discussed the recent sell-off in AI-related stocks. During the lightning round, a caller queried about the stock, and Cramer responded: I like CCJ because it’s a real uranium company. It’s not a mock uranium company that a lot of other […]
Option Care (OPCH) Q1 Earnings Beat Estimates
Option Care (OPCH) delivered earnings and revenue surprises of +7.15% and -3.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for
Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ADUS or ELAN: Which Is the Better Value Stock Right Now?
ADUS vs. ELAN: Which Stock Is the Better Value Option?